Stemson is going to use minipigs in the next stage of their hair cloning research

pegasus2

Senior Member
My Regimen
Reaction score
4,746
male pattern baldness also occurs to late in life for it to be eliminated via selective pressure. It's only modern times where people delay reproduction into their mid-20s+, nevermind 40+ where male pattern baldness is most prevalent
That's what I meant. Most people historically had kids before it set in. It's like asking why wrinkles weren't weeded out lol
 

froggy7

Experienced Member
My Regimen
Reaction score
193
"Just watched the Stemson video and it seems like the first product will only be available to a select few i.e. those with money. Does that suggest that the bulk of us will have to wait longer to get access to the technology? say Product 1 is available in 10years and Product 2 available in 15years…"
 

FilthyFrancis

Established Member
My Regimen
Reaction score
470
"Just watched the Stemson video and it seems like the first product will only be available to a select few i.e. those with money. Does that suggest that the bulk of us will have to wait longer to get access to the technology? say Product 1 is available in 10years and Product 2 available in 15years…"
Alexey called me this morning and said "80% discount for HairLossTalk.com user froggy7 and happy new year"
 

pegasus2

Senior Member
My Regimen
Reaction score
4,746

werefckd

Experienced Member
My Regimen
Reaction score
584
There is no Tsuji anymore and dNovo is where Stemson was 2 years ago, despite being founded in the same year
 

werefckd

Experienced Member
My Regimen
Reaction score
584
"Just watched the Stemson video and it seems like the first product will only be available to a select few i.e. those with money. Does that suggest that the bulk of us will have to wait longer to get access to the technology? say Product 1 is available in 10years and Product 2 available in 15years…"
Where was this posted?
 

froggy7

Experienced Member
My Regimen
Reaction score
193

Roeysdomi

Experienced Member
My Regimen
Reaction score
296
There is no Tsuji anymore and dNovo is where Stemson was 2 years ago, despite being founded in the same year
Lol they solved any problem of hair results so far (that stemson and tsuji still stuck on )
, they only need to test in human and make it scaleable and they are done.(based on the result the had)
 

badnewsbearer

Established Member
My Regimen
Reaction score
80
"Just watched the Stemson video and it seems like the first product will only be available to a select few i.e. those with money. Does that suggest that the bulk of us will have to wait longer to get access to the technology? say Product 1 is available in 10years and Product 2 available in 15years…"
when are you finnaly getting your criotherapy
 

Raccooner

Established Member
My Regimen
Reaction score
82
Lol they solved any problem of hair results so far (that stemson and tsuji still stuck on )
, they only need to test in human and make it scaleable and they are done.(based on the result the had)
How do you know this for sure? What results do you speak of?
 

werefckd

Experienced Member
My Regimen
Reaction score
584
Interesting

Dr. Bharti is leading the first Phase I/IIa clinical trial in the US using autologous iPSC-derived cells to treat the retinal pigment epithelium in age-related macular degeneration (AMD). His pioneering work in combining iPSC-derived cells together with scaffolds and transferring those solutions into cutting edge, highly controlled and compliant manufacturing processes positions him to guide Stemson’s efforts in similar areas.

Signs of a clinical trial planning/preparation
 

MrV88

Senior Member
My Regimen
Reaction score
1,246
Gimme the pigs, I'll pull the hairs out by myself and get em implanted by a shady Doctor somewhere in 3. world country... wondering if I could get back my hair when I'm 50
 

werefckd

Experienced Member
My Regimen
Reaction score
584

Kapil Bharti, Ph.D. is a Senior Investigator at the National Eye Institute at the National Institutes of Health. He is a world renowned expert in regenerative medicine, stem cell biology, and developmental biology of the eye. Dr. Bharti is leading the first Phase I/IIa clinical trial in the US using autologous iPSC-derived cells to treat the retinal pigment epithelium in age-related macular degeneration (AMD). His pioneering work in combining iPSC-derived cells together with scaffolds and transferring those solutions into cutting edge, highly controlled and compliant manufacturing processes positions him to guide Stemson’s efforts in similar areas.

George Murphy, M.D. is Co-Director of the Harvard Stem Cell Institute (HSCI) Skin Program, Professor of Pathology at Harvard Medical School, and the Director of the Program in Dermatopathology at the Brigham and Women’s Hospital. He is a Harvard-trained skin pathologist with 40 years of experience as a physician-scientist focused on understanding the pathobiology of human and murine skin. He has authored over 300 peer-reviewed publications and numerous textbooks in the field of skin pathology and has maintained a continuously NIH-funded research lab for over 35 years. Through this Harvard-based research and his role at the HSCI, Dr. Murphy has a major interest in how the genetic and epigenetic factors and related microenvironmental niches participate in complex regenerative phenomena such as scarless wound healing and hair follicle cycling and neogenesis.

According to the type of talent Stemson is gathering, it looks like they are starting to plan the next phase of their research guys (i.e. clinical trials may be starting to show in the horizon).

If we get a date estimate for that in 2022 it will be great. I'm expecting more clues in their next hires.
 

froggy7

Experienced Member
My Regimen
Reaction score
193
they are moving forward, they are happy, even if they fail, it will be easier for the next companies, I hope that the rest will compete with them
 
Top